Hemoglobins
10
0
0
6
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
30.0%
3 terminated out of 10 trials
66.7%
-19.8% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Electronic Triggers: Messaging After A1C EHR Alert
Association Between Preoperative HALP and Immediate Postoperative Outcomes
Noninvasive Hemoglobin Monitoring for Maintaining Hemoglobin Concentration Within the Target Range
Comparison of the Automatized and the Optimized Carbon Monoxid Rebreathing Protocol
Haemoglobin Measurement for Babies
Non-invasive Measurement of Hemoglobin in Infants and Neonates
Effect Aerobic Training on Women With Breast Cancer After Chemotherapy
A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia
A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia
A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer